Minimal residual disease detection in b-cell malignancies by assessing IgH rearrangement

Hematology and Cell Therapy

Volumn 39, Issue 3, 1997, Pages 119-124

  Maloum, K ^a   Pritsch, O ^b   Dighiero, G ^b  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b INSTITUT PASTEUR   (France)

Author keywords

B cell malignancies; IgH genes; MRD; PCR

Indexed keywords

FLUDARABINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; B CELL LEUKEMIA; BONE MARROW TRANSPLANTATION; CANCER CHEMOTHERAPY; CHILD; CHRONIC LYMPHATIC LEUKEMIA; DISEASE ACTIVITY; GENE AMPLIFICATION; GENE REARRANGEMENT; HUMAN; IMMUNOGLOBULIN VARIABLE REGION; LEUKEMIA; MULTIPLE MYELOMA; POLYMERASE CHAIN REACTION; REVIEW; TREATMENT OUTCOME;

B-LYMPHOCYTES; GENE REARRANGEMENT, B-LYMPHOCYTE, HEAVY CHAIN; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; LEUKEMIA, B-CELL, CHRONIC; LEUKEMIA, LYMPHOCYTIC, ACUTE; LYMPHOMA, B-CELL; NEOPLASM, RESIDUAL;

EID: 0030875150     PISSN: 12693286     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00282-997-0119-z     Document Type: Review

References (52)

1. Bartram CR (1993) Detection of minimal residual leukemia by the polymerase chain reaction: potential implications for therapy. Clin Chim Acta 217: 75-83
2. Binet JL, Auquier A, Dighiero G, et al (1981) A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis. Cancer 48: 198-206
3. Biondi A, Yokota S, Hansen-Hagge TE, et al (1992) Minimal residual disease in childhood acute lymphoblastic leukemia: analysis of patients of continuous complete remission or with consecutive relapse. Leukemia 6: 282-288
4. Brisco MJ, Tan LW, Osborn AM, et al (1990) Development of a highly sensitive assay, based on the polymerase chain reaction, for rare B-lymphocyte clones in a polyclonal population. Br J Haematol 75: 163-167
5. Brisco MJ, Codon J, Hughes E, et al (1993) Prognostic significance of detection of monoclonality in remission marrow in acute lymphoblastic leukemia in chilhood. Leukemia 7: 1514-1520
6. Brisco MJ, Hughes SH, Neoh PJ, et al (1996) Relationship between minimal residual disease and outcome in adult lymphoblastic leukemia. Blood 87: 5251-5256
7. Brugiatelle M, Callea V, Morabito M, et al (1989) Immunologic and molecular evaluation of residual disease in B-cell chronic lymphocytic leukemia patients in clinical remission state. Cancer 63: 1979-1984
8. Brugiatelle M, Claisse JF, Lenormand B, et al (1995) Clinical outcome of B-cell chronic lymphocytic leukemia (CLL) patients in clinical remission phase evaluated at phenotypic level (abstract). Blood 86 [Suppl 1]: 347a
9. Campana D, Pui CH (1995) Detection of minimal residual disease in acute leukemia: methodologic advances and significance. Blood 85: 1416-1434
10. Carlo-Stella C, Mangoni L, Dotti GP, et al (1995) Techniques for detection of minimal residual disease. Leuk Lymph 18: 75-80
11. Cheson B, Bennett J, Rai K, et al (1988) Guidelines for clinical protocols for chronic lymphocytic leukemia: recommandations of the NCI sponsored working group. Am J Hematol 29: 152-163
12. Cheson BD, Bennett JM, Grever M, et al (1996) National cancer institute-sponsored working group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment. Blood 87: 4998-4997
13. Chim JC, Coyle LA, Yaxley JC, et al (1996) The use of IgH finger-printing and ASO-dependent PCR for the investigation of residual disease (MRD) in ALL. Br J Haematol 92: 104-115
14. Cleary ML, Chao J, Warnke R, Sklar J (1984) Immunoglobulin gene rearrangement as a diagnostic criterion of B-cell lymphoma. Proc Natl Acad Sci USA 81: 593-597
15. Deane M, Norton JD (1990) Detection of immunoglobulin gene rearrangement in B lymphoid malignancies by polymerase chain reaction gene amplification. Br J Haematol 74: 251-256
16. Deane M, Pappas H, Norton JD (1991) Immunoglobulin heavy chain gene fingerprinting reveals widespread oligoclonality in B-lineage acute lymphoblastic leukemia. Leukemia 5: 832-838
17. Eclache V, Magnac C, Pritsch O, et al (1995) Complete nucleotide sequence of Ig V genes in three cases of Burkitt lymphoma associated with AIDS. Leuk Lymph 20: 281-290
18. French cooperative group on chronic lymphocytic leukemia (1987) Prognostic and therapeutic advances in chronic lymphocytic leukemia management: the experience of the French cooperative group. Semin Hematol 24: 275-290
19. Gazitt Y, Readind CC, Hoffman R, et al (1995). Purified CD34+ lin- Thy+ stem cells do not contain clonal myeloma cells. Blood 86: 381-389
20. Greaves M (1997) Silence of the leukemic clone. N Engl J Med 336: 367-369
21. Gribben JG, Freedman AS, Neuberg D, et al (1991) Immunological purging of marrow assessed by PCR before autologous bone marrow transplantation for B-cell lymphoma. N Engl J Med 325: 1525-1533
22. Gribben JG, Neuberg DN, Barber M, et al (1994) Detection of residual lymphoma cells by polymerase chain reaction in peripheral blood is significantly less predictive for relapse than detection in bone marrow. Blood 83: 3800-3807
23. International Workshop on chronic lymphocytic leukemia (1989) Chronic lymphocytic leukemia: recommandations for diagnosis, staging and response criteria. Ann Intern Med 110: 236-238
24. Kabat EA, Wu TT, Perry HM, et al (1991) Sequences of proteins of immunological interest. Bethesda, Maryland, US Department of Health and Human Services
25. Kirkham PM, Schroeder HW (1994) Antibody structure and the evolution of immunoglobulin V gene segments. Semin Immunol 6: 347-360
26. Kitchingman GR (1994) Residual disease detection in multiple follow-up samples in children with acute lymphoblastic leukemia. Leukemia 8: 395-401
27. Korsmeyer SJ (1985) Hierarchy of immunoglobulin gene rearrangement in B-cell leukemias. In: Waldmann TA moderator. Molecular genetic analysis of human lymphoid neoplasm: Immunoglobulin genes and c-myc oncogene. Ann Intern Med 102: 479-510
28. Kurokawa T, Kinoshita T, Ito T, et al (1996) Detection of minimal residual disease B-cell lymphoma by a PCR mediated Rnase protection assay. Leukemia 10: 1222-1231
29. Landman-Parker J, Aubin J, Delabesse E, et al (1996) Simplified strategies for minmal residual disease detection in B-cell precursor acute lymphoblastic leukaemia. Br J Haematol 95: 281-290
30. Langlands K, Goulden NJ, Stewart CG, et al (1994) False-positive residual disease assessment after bone marrow transplant in acute lymphoblastic leukemia (letter). Blood 84: 1352-1353
31. Maloum K , Magnac C, Pritsch O, et al (1995) Semi-quantitative automated method for assessment of minimal resdual disease in chronic lymphocytic leukemia (abstract). Blood 86 [Suppl 1]: 349a
32. Maloum K, Magnac C, Sutton L, et al (1996) Minimal residual disease assessment in chronic lymphocytic leukemia (abstract). Blood 88 [Suppl 1]:77a
33. Negrin RS and Blume KG (1991) The use of the polymerase chain reaction for the detection of minimal residual malignant disease. Blood 78: 255-258
34. Nizet Y, Martiat P, Vaerman JL, et al (1991) Follow-up of residual disease (MRD) in B lineage acute leukaemias using a simplified PCR strategy: evolution of MRD rather than its detection is correlated with clinical outcome. Br J Haematol 79: 205-210
35. Pritsch O, Benasseur AL, Leclerc E, et al (1995) Etude de la maladie résiduelle dans les cellules souches CD34+ dans la maladie de Kahler (abstact). Nouv Rev Fr Hematol 37: 87
36. Provan D, Bartlett-Pandite L, Zwicky C, et al (1996) Eradication of polymerase chain reaction-detectable Chronic Lymphocytic Leukemia cells is associated with improved outcome after bone marrow transplantation. Blood 88: 2228-2235
37. Rai KR, Peterson B, Elias L, et al (1996) A randomized comparison of fludarabine and chlorambucil for patients with previously untreated chronic lymphocytic leukemia. A CALGB, SWOG, CTG/NCI-C and ECOG inter-group study. Blood 88 [Suppl 1]: 141a
38. Roberts WM, Estrov Z, Ouspenskaia MV, et al (1997) Measument of residual leukemia during remission in childhood acute lymphoblastic leukemia. N Eng J Med 336: 317-323
39. Robertson LE, Huh YO, Butler JJ, et al (1992) Response assessment in chronic lymphocytic leukemia after fludarabine plus prednisone: clinical, pathologic, immunophenotypic, and molecular analysis. Blood 80: 29-36
40. Rozman C, Montserrat E (1995) Chronic lymphocytic leukemia. N Engl J Med 333: 1052-1057
41. Schiller G, Vescio R, Freytes C, et al (1995) Transplantation of CD34+ peripheral blood progenitor cells after high dose chemotherapy for patients with advanced multiple myeloma. Blood 86: 390-397
42. Sutton L, Maloum K, Boccaccio C, et al (1994) Autologous BMT with anti-B monoclonal antibodies purged marrow in 2 patients with advanced chronic lymphocytic leukemia (abstract). EBMT 20th annual meeting of European group for bone marrow transplantation, Harrogate, England, p. 105
43. Tonegawa S (1983) Somatic generation of antibody diversity (review). Nature 302: 575-581
44. Van dongen JJM, Breit TM, Adriansen HJ, et al (1992) Detection of minimal residual disease in acute leukemia by immunological marker analysis and polymerase chain reaction. Leukemia 6 [Suppl 1]: 47-59
45. Vuillier F, Claisse JF, Vandenvelde C, et al (1992) Evaluation of residual disease in B-cell chronic lymphocytic leukemia patients in clinical and bone-marrow remission using CD5-CD19 markers and PCR study of gene rearrangements. Leuk Lymph 7: 195-204
46. Waldmannn TA (1987) The rearrangement of immunoglobulin and T cell receptor genes in human lymphoproliferative disorders (review). Adv Immunol 40: 1-59
47. Westbrook CA, Dodge R, Szatrowski TP, et al (1996) PCR monitoring of minimal residual disease identifies good outcome in BCR/ABL positive acute lymphoblastic leukemia (ALL) (abstract). Blood 88 [Suppl 1]: 477a
48. Wormann B (1993) Implications of detection minimal residual disease. Curr Opin Oncol 5: 3-12
49. Yamada M, Hudson S, Tornay O, et al (1989) Detection of minimal disease in hematopoietic malignancies of B-cell lineage by using third-complementary-determining region (CDRIII) specific probes. Proc Natl Acad Sci USA 86: 5123-5127
50. Yamada M, Wasserman R, Lange B, et al (1990) Minimal residual disease in childhood B-lineage lymphoblastic leukemia. N Engl J Med 323: 448-455
51. Yancopoulos GD, Alt FW (1986) Regulation of the assembly and expression of variable-region genes. Ann Rev Immunol 4: 339-368
52. Yokota S, Hansen-Hagge TE, Ludwig WD, et al (1991) Use of polymerase chain reaction to monitor minimal residual disease in acute lymphoblastic leukemia patients. Blood 77: 331-339